Speciality: Dermatology
Description:
A warm welcome to all the medical professionals in this interesting session on Understanding Urticaria
Urticaria, commonly known as hives, is a skin condition characterized by the sudden appearance of red, itchy welts or raised areas on the skin. These welts can vary in size and may appear on any part of the body, often changing location or shape within a few hours. Urticaria is typically triggered by allergic reactions to substances like food, medications, insect stings, or even environmental factors like heat, cold, or stress.
There are two main types of urticaria: acute and chronic. Acute urticaria lasts for less than six weeks and is usually linked to a clear allergen. Chronic urticaria, on the other hand, persists for six weeks or more and often has no identifiable cause. Treatment usually involves antihistamines to reduce itching and swelling, though more severe cases may require corticosteroids or immunosuppressants. Identifying and avoiding triggers, when possible, is key to preventing flare-ups and managing the condition effectively.
Therefore, get an overall knowledge of understanding urticaria
See More Webinars @ Hidoc Webinars
1.
Beyond What Is Visible in Myelofibrosis?
2.
FDA approves rivanetin as the first-line treatment for lung cancer.
3.
In high-risk muscle invasive urothelial cancer, adjuvant pembrolizumab improves disease-free survival.
4.
New First-Line Option for Advanced ALK-Positive Lung Cancer
5.
Certain surgical gestures during prostate removal linked to better sexual function recovery
1.
Tremelimumab: A Potential Breakthrough in Cancer Treatment
2.
The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy
3.
Artificial Intelligence for Early Cancer Detection Leveraging Multi-Omics: A Comprehensive Review
4.
Harnessing Snake Venom in Hematology: From Toxins to Life-Saving Therapeutics
5.
Unlocking the Potential of SCD: A Comprehensive Guide to Diagnosis and Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
2.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
3.
Updates on Standard V/S High Risk Myeloma Treatment
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation